The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Determinants of survival in 356 patients failing frontline HMA-Ven for newly-diagnosed AML.
 
Mahnoor Fatima
No Relationships to Disclose
 
Sudhesh Kumar
No Relationships to Disclose
 
Momna Warraich
No Relationships to Disclose
 
Kristen McCullough
No Relationships to Disclose
 
Aref Al-Kali
Consulting or Advisory Role - Novartis
Research Funding - ALX Oncology; Aprea Therapeutics; Astex Pharmaceuticals; Bristol-Myers Squibb; Celgene; Hemavant Sciences; Novartis
 
Hassan Alkhateeb
No Relationships to Disclose
 
Kebede Begna
No Relationships to Disclose
 
Abhishek Mangaonkar
Research Funding - Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Incyte (Inst); Novartis (Inst)
 
Antoine Saliba
Consulting or Advisory Role - Novartis (Inst)
Research Funding - Chordia Therapeutics (Inst); Daiichi Sankyo/UCB Japan (Inst); Gilead Sciences (Inst); Kura Oncology (Inst)
 
Mark Litzow
Honoraria - Amgen; BeiGene Shanghai
Speakers' Bureau - Amgen; BeiGene Shanghai
Research Funding - Actinium Pharmaceuticals; Amgen; Astellas Pharma; Syndax
Travel, Accommodations, Expenses - Amgen; BeiGene Shanghai
 
William Hogan
No Relationships to Disclose
 
Mithun Shah
Honoraria - Omeros
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Celgene/Bristol-Myers Squibb (Inst); Kura Oncology (Inst); Marker Therapeutics (Inst)
 
Mrinal Patnaik
Honoraria - AstraZeneca (Inst); CTI/SOBI (Inst); GlaxoSmithKline
Consulting or Advisory Role - Kura Oncology (Inst)
Research Funding - Epigenetix (Inst); Kura Oncology (Inst); Polaris (Inst); Solutherapeutics (Inst); Stemline Therapeutics (Inst)
 
Animesh Pardanani
No Relationships to Disclose
 
Talha Badar
Honoraria - Amgen; Ascentage Pharma; Syndax; Takeda
Research Funding - Amgen; Takeda
 
James Foran
Stock and Other Ownership Interests - Aurinia Pharmaceuticals
Consulting or Advisory Role - Syndax
Research Funding - Celgene/Bristol-Myers Squibb (Inst); Chordia Therapeutics; Kura Oncology (Inst); roivant (Inst); Sellas Life Sciences (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Peerview
 
Jeanne Palmer
No Relationships to Disclose
 
Cecilia Arana Yi
Consulting or Advisory Role - Blueprint Medicines; Bristol-Myers Squibb/Pfizer; Cogent Biosciences
Speakers' Bureau - Curio Science
Research Funding - Blueprint Medicines
Travel, Accommodations, Expenses - dava oncology
 
Ayalew Tefferi
No Relationships to Disclose
 
Naseema Gangat
Consulting or Advisory Role - Agios; Disc Medicine